How The Compound’s view on $AAPL changed

2026-09-11Bullish
“The Most Interesting Macro Moment of My Lifetime | TCAF 259”
iPhone Duo is a strong product expected to sell out immediately; the $2,000 launch price is lower than anticipated, creating upside potential for future iterations.

Um, what do you think about the iPhone Duo? I I think I need to get it because the last iPhone I got was really bad. So, I need an upgrade very soon, but uh I'd like to have a lot of real estate.

I was very on the fence going into the announcement of like I don't know. I could see it like going either way. And 30 seconds in, I'm blown away. I am all the way in. I think it's so spectacular. I I think it's going to be a slam dunk.

2026-09-08Bullish
“Stocks Aren't as Expensive as You Think | WAYT?”
Upcoming foldable iPhone expected to be a successful product launch driven by consumer desire for reduced digital engagement.

and then we will discuss Apple’s $2,000 phone.

I think Apple was on the list,

Ah, " Apple" for example.

On June 20, 2025, we did an episode about "Taff" with me, Michael, Todd Son, and Josh. And Michael, I said that we are at a very critical juncture for Apple.

very critical juncture for Apple. This is a ratio chart that you, Michael, shared in the previous podcast, and I ticked it when that episode aired. It simply shows the price of Apple divided by the SPY index.

Your point of view was that we were facing a very important dividing line , where the question was: "Will Apple collapse and the situation become very bad, or will this be a bounce point?", and that is exactly what happened; It was a reversal point, which, I think, reflects the importance of technical analysis, doesn't it?

I have seen a very important level that the stocks have touched several times and have maintained that line.

2026-09-01Bullish
Subscribe or start a trial to unlock this step
1 earlier entry need a subscription
The latest 2 are free to read. Earlier entries keep their date and direction; the text unlocks with a subscription.
Subscribe · 30-day full trial